ALKtALK | Sunday 7pm ET
Be informed. Be empowered.
This Sunday, Jonathan Riess, MD & Johanna Han, MSc (UC Davis) break down ALK+ clinical trials and single-patient INDs—what they are, what they’re not, and what to realistically expect.
English
ALK Positive
3.6K posts
ALK Positive
@ALKPositiveinc
We are a patient-driven organization, dedicated to improving the life expectancy & quality of life for ALK-positive cancer patients worldwide. #StrongerTogether
United States Katılım Mayıs 2018
915 Takip Edilen2.9K Takipçiler
ALK Positive retweetledi
Come to learn how to manage adverse events associated with ALK directed therapy - with a focus on CNS side effects and weight gain
#ELCC2026
English
What does it actually mean to be here at ESMO ELCC?
In this video, Ken Culver shares how we’re spending our time — not just attending lectures, but speaking with investigators, connecting with other advocates, and meeting with industry.
Improving outcomes one meeting at a time.
English
ALK Positive retweetledi
Dr @NarjustFlorezMD’s shines a light on ⬆️ in #lungcancer in young people (<50) @ #ELCC26. More prevalent in women especially Asian & Hispanic. 4th most common cancer in adults <50 years. Tends to be more aggressive. Should consider strategies like RT & surgery for optimal chance
English
@lungoncdoc @myESMO We love seeing progress in ALK and all lung cancers. May this continue. 👏👏
English
ALK Positive retweetledi
In case you missed it: real progress is happening in ALK+ NSCLC.
And we are just getting started. Here’s to what’s next.
@myESMO #ELCC26
Yvonne Diaz@Yvonne_Diaz_
Dr @bensolomon1 showcases progress in ALK @myESMO #ELCC26. With more effective therapies & moving to earlier disease will can improve long term survival & one day help find a cure for ALK #LCSM
English
@Yvonne_Diaz_ @OncogeneCancer @bensolomon1 @myESMO @IASLC @ALKNewsNow @ALKPositiveAUS @AlkRos1France @FindtheCureAlk @PeterMacCC @TOGAANZ Great presentation Dr @bensolomon1. Grateful for your and all the other researchers’ dedication to improving outcomes in ALK.
English
ALK Positive retweetledi
Dr @bensolomon1 showcases progress in ALK @myESMO #ELCC26. With more effective therapies & moving to earlier disease will can improve long term survival & one day help find a cure for ALK #LCSM
English
Living with ALK+ cancer comes with important decisions. You deserve clarity and confidence in your path.
The ALK Positive Second Opinion Program connects you to:
✔️ Curated ALK-educated providers
✔️ Financial assistance
✔️ Remote consult options
alkpositive.org/living.../seco…
English
Join us TONIGHT for Clinical Trials Connect—a supportive space to learn, ask questions, and explore your options.
Featuring Ellee Urban + Hosted by Jeff Sturm
🗓 March 19 | 7 PM ET
🔗 alkpositive.org/event/clinical…
English
ALK Positive retweetledi
On Saturday, our President Tyler Jacks, was awarded the 2025 @AmericanCancer Medal of Honor, one of the highest distinctions in the cancer field.
We are proud that Tyler’s leadership is being recognized at this level. Please join us in congratulating Tyler on this honor
ACSNews@ACSNews
Dr. Tyler Jacks honored at @AmericanCancer Medal of Honor ceremony in Washington, D.C. -"I am pleased to receive this on behalf of the many trainees & colleagues with whom I have worked over the years & those who have suffered from cancer." @billdahutmd Shane Jacobson/ACS CEO
English
ALK Positive retweetledi
Join us at the @AACR 2026 Annual Meeting in San Diego where we'll present new clinical and preclinical data for our ROS1+ NSCLC program. Learn more: investors.nuvalent.com/2026-03-17-Nuv…
#AACR26
English
Missed it live? The ALKtALK replay with Dr. Alex Drilon is now available.
Learn about new data and emerging directions for neladalkib (NVL-655) and how precision oncology continues to shape treatment for ALK-positive lung cancer.
🎥 Watch the replay:
youtu.be/PRrfLmIQb9I?si…
YouTube
English
ALK Positive retweetledi
At #BTOG26 we were proud to present a poster w @EgfrUk UK & @Uni_of_Essex on a case report of surgery in a stage 4 EGFR #lungcancer patient.
This case shows that for some stage 4 EGFR+ patients surgery deserves real consideration.
Open conversation. Challenge convention.
#LCSM
English
ALK Positive retweetledi
Proud to co-author this important piece on navigating cancer info in the age of Google, social media & AI.
We chat about: how to spot credible sources, use AI wisely, & strengthen shared & informed decision-making.
tandfonline.com/doi/full/10.10…
English
Join ALKtALK this Sunday:
New Data, New Directions: Neladalkib (NVL-655) & Precision Oncology in ALK+ Cancer
Featuring Alexander Drilon, MD (MSK)
🧬 Latest clinical data
🔬 How trials move toward access
🧪 Biomarker-driven insights
💬 Live Q&A
📅 March 1, 2026
🕖 7 PM ET
English
Today is National Care Partner Day, to all those supporting loved ones with ALK-positive cancer — your strength and love carry more than most will ever know.
We are deeply grateful.
Join our next Care Partner Check-In
Feb 26 @ 9PM ET
alkpositive.org/events/categor…
English
🎥 Clinical Trials Connect Recording Now Available
youtube.com/playlist?list=…
Missed it live? Watch our Clinical Trials Connect session with Jeff Sturm, Dr. Ken Culver, Sadia Yaakov, and ALK Positive Medical Committee members.
English
We’re at TTLC 2026 in Huntington Beach, CA!
Targeted Therapies of Lung Cancer focuses on breakthrough targeted treatments, resistance research, and the future of precision care. We're here to stay close to the science, build partnerships, and advance progress in ALK+ research.
English
ALK Positive retweetledi
Patient advocacy belongs in #lungcancer surgery.
That's why we're pleased to show how in a published article with Dr @pompili_cecilia, @Antonio_Ungaro_ & 6 other leading European patient orgs.
Our Chair @Yvonne_Diaz_ highlights 3 urgent needs. 👇
oncogeneresearch.org/patient-publis…
#LCSM
English